Press Releases
Search
-
15 May 2008
bioMérieux and FIND to Collaborate on Infectious Disease Diagnostics
Marcy l’Etoile, France / Geneva, Switzerland - May 15, 2008. bioMérieux, a leader in the field of in vitro diagnostics and FIND (the Foundation for Innovative New Diagnostics), a Swiss non-profit foun...
-
28 Apr 2008
biomerieux-first-quarter-2008-business-review
April 29, 2008. Sales up 6.2% like-for-like.
-
15 Apr 2008
bioMérieux Bestowed 2007 Frost & Sullivan European Healthcare-Associated Infection Control Technology Leadership Award
April 15, 2008. The 2007 European Healthcare-Associated Infection Control Technology Leadership Award is conferred upon bioMérieux in recognition of its unparalleled leadership and commitment toward h...
-
03 Apr 2008
University of Sunderland and bioMérieux Collaborate in New Research Significantly Improving the Identification of Pseudomonas aeruginosa. A Major Cause of Death in Cystic Fibrosis Patients
April 3, 2008 . A team of researchers from the University of Sunderland and bioMérieux, a leading company in the field of in vitro diagnostics, have achieved a new step in the fight against Pseudomona...
-
17 Mar 2008
2007 Financial Results
March 17, 2008. 2007: Clear improvement in growth and in operating margin before non-recurring items...
-
17 Mar 2008
bioMérieux and Hitachi High-Technologies Corporation Enter into Long-Term Strategic Partnership Focus on Microbiology and Molecular Diagnostics
March 17, 2008 . bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics has entered into a long-term strategic partnership with Hitachi High-Technologies Corporation of Japan.
-
13 Mar 2008
FDA Clears bioMérieux’s VIDAS® NT-proBNP
A High Medical Value Test for Diagnosis of Heart Failure March 13, 2008 . bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. F...
-
06 Mar 2008
bioMérieux Opens New Subsidiary in Singapore
March 6, 2008. bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, announces the opening of a subsidiary in Singapore. This 38th subsidiary is another milestone for the co...
-
26 Feb 2008
bioMérieux’s Food Safety Handbook is Now Available
Marcy l'Etoile, France - February 26, 2008. bioMérieux, a world leader in industrial microbiology control, announces that the first Food Safety Handbook: Microbiological Challenges is now available fo...
-
14 Feb 2008
bioMérieux and Wescor Bring a New Gram Staining Instrument for Enhanced Microbiology Laboratory Workflow
Marcy l’Etoile (France - February 14, 2008 . bioMérieux (Euronext: BIM) and Wescor, an ELITech Group Company have signed an agreement by which bioMérieux will become Wescor’s exclusive worldwide partn...
-
31 Jan 2008
bioMérieux and Shanghai Kehua Bio-engineering Build Joint Venture
January 31, 2008 . Shanghai Kehua Bio-engineering (Stock Code: 002022) and bioMérieux (Euronext: BIM) announce the creation of a Shanghai-based joint venture to which bioMérieux will transfer micropla...
-
22 Jan 2008
2007 Business Review - 2007: sales up 7.4% like-for-like
Marcy l'Etoile, France - January 22, 2008.
-
15 Jan 2008
Quidel and bioMérieux Announce a Global Strategic Alliance in Rapid Diagnostics
January 15, 2008. Quidel Corporation (NASDAQ: QDEL) and bioMérieux (Euronext: BIM) have agreed to form a long-term global alliance in the area of rapid clinical diagnostics for the point-of-care. bioM...
-
10 Jan 2008
Sysmex and bioMérieux Form a Commercial Joint Venture for the Japanese In Vitro Diagnostics Market
January 10, 2008 . Sysmex Corporation (HQ: Kobe, Japan; President: Hisashi Ietsugu) and bioMérieux (Euronext: BIM) announce they have signed an agreement by which Sysmex will take a 34% equity stake i...
-
08 Jan 2008
bioMérieux Transfers Certain R&D and Manufacturing Activities to France
January 8, 2008. bioMérieux (Euronext: BIM) announces the transfer to France of R&D and certain manufacturing activities currently at its Boxtel site in the Netherlands. The transfer will take place g...